Related Experiment Video
Updated: Sep 12, 2025

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Potential mechanism of 25R-inokosterone in the treatment of osteoporosis: Based on bioinformatics and molecular
Jun Tan1,2, Liwei Huo2, Mengting Hu3
1Guangdong Provincial People's Hospital's Nanhai Hospital, Foshan, Guangdong Province, China.
Abstract:
25R-inokosterone, a sterone derived from Achyranthes bidentata Bl., has potential anti-osteoporotic effects. However, the underlying mechanism of 25R-inokosterone in the treatment of osteoporosis is unknown. The aim of this study was to investigate the molecular mechanism of 25R-inokosterone's anti-osteoporosis by network pharmacology and molecular docking. First, the structural formula of 25R-inokosterone was obtained by PubChem and potential targets were predicted by SwissTargetPredictive. The genes of osteoporosis (OP) were obtained by GeneCards, OMIM, therapeutic target database and database of gene-disease associations. Protein interactions and functional enrichment of potential targets were analyzed using STRING, gene ontology, and Kyoto encyclopedia of genes and genomes pathway databases. Finally, the hub targets were identified by network pharmacology, and the interaction of their hub targets with 25R-inokosterone was verified by molecular docking and molecular dynamics simulations. The results showed that 43 potential targets were associated with the mechanism of 25R-inokosterone for OP treatment. Enrichment analysis showed that hub genes were mainly associated with prolactin signaling pathway, aldosterone-regulated sodium reabsorption, phosphatidylinositol-3 kinase-Akt signaling pathway, and mTOR signaling pathway. Molecular docking showed that 25R-inokosterone was associated with PIK3CA, MTOR, TNF, MAPK3, CDK2, and NTRK1 with good affinity. Among them, 25R-inokosterone has the highest affinity with PIK3CA/MTOR, which is supported by molecular dynamics simulations. Our findings suggested that 25R-inokosterone may against OP by regulating multiple targets such as PIK3CA, MTOR, TNF, MAPK3, CDK2, and NTRK1 and phosphatidylinositol-3 kinase/AKT/mTOR signaling pathway. These findings provide a theoretical basis for the treatment of OP.
More Related Videos
07:12Semiautomated Longitudinal Microcomputed Tomography-based Quantitative Structural Analysis of a Nude Rat Osteoporosis-related Vertebral Fracture Model
Published on: September 28, 2017
08:53Drug Treatment and In Vivo Imaging of Osteoblast-Osteoclast Interactions in a Medaka Fish Osteoporosis Model
Published on: January 1, 2017
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...